We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This publication is intended for Valuation Officers. It may contain links to internal resources that are not available through this version.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Patients who present with acute or worsening signs and symptoms of keratitis should be referred promptly to an ophthalmology specialist.
How to spot Batrachochytrium salamandrivorans, what to do if you suspect it and measures to prevent its spread.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Despicable people who create sexually explicit ‘deepfakes’ will face prosecution under a new law announced by the government today (16 April 2024).
The Yellow Card Biobank will today start investigating a new group of medicines known as Direct Oral Anticoagulants
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.